Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Times Interest Earned (2020 - 2024)

Gyre Therapeutics (GYRE) has disclosed Times Interest Earned for 9 consecutive years, with $25.62 as the latest value for Q1 2024.

  • Quarterly Times Interest Earned rose 147.23% to $25.62 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $51.31 through Dec 2024, up 149.07% year-over-year, with the annual reading at -$25.92 for FY2023, 486.95% down from the prior year.
  • Times Interest Earned for Q1 2024 was $25.62 at Gyre Therapeutics, up from $10.36 in the prior quarter.
  • The five-year high for Times Interest Earned was $25.62 in Q1 2024, with the low at -$2300.0 in Q3 2020.
  • Average Times Interest Earned over 3 years is -$660.21, with a median of -$183.23 recorded in 2020.
  • Peak annual rise in Times Interest Earned hit 147.23% in 2024, while the deepest fall reached 147.23% in 2024.
  • Over 3 years, Times Interest Earned stood at -$376.82 in 2020, then surged by 102.75% to $10.36 in 2023, then skyrocketed by 147.23% to $25.62 in 2024.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at $25.62, $10.36, and -$376.82 for Q1 2024, Q1 2023, and Q4 2020 respectively.